Paul Kleihues
Paul Kleihues
Medical Faculty, University of Zurich
Dirección de correo verificada de
Citado por
Citado por
The 2016 World Health Organization classification of tumors of the central nervous system: a summary
DN Louis, A Perry, G Reifenberger, A Von Deimling, D Figarella-Branger, ...
Acta neuropathologica 131, 803-820, 2016
The 2007 WHO classification of tumours of the central nervous system
DN Louis, H Ohgaki, OD Wiestler, WK Cavenee, PC Burger, A Jouvet, ...
Acta neuropathologica 114, 97-109, 2007
Pathology and genetics of tumours of the nervous system
P Kleihues
(No Title), 2000
World cancer report
BW Stewart, P Kleihues
IARC press, 2003
The new WHO classification of brain tumours
P Kleihues, PC Burger, BW Scheithauer
Brain pathology 3 (3), 255-268, 1993
Genetic pathways to primary and secondary glioblastoma
H Ohgaki, P Kleihues
The American journal of pathology 170 (5), 1445-1453, 2007
Genetic pathways to glioblastoma: a population-based study
H Ohgaki, P Dessen, B Jourde, S Horstmann, T Nishikawa, PL Di Patre, ...
Cancer research 64 (19), 6892-6899, 2004
Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas
H Ohgaki, P Kleihues
Journal of Neuropathology & Experimental Neurology 64 (6), 479-489, 2005
Epidemiology and etiology of gliomas
H Ohgaki, P Kleihues
Acta neuropathologica 109, 93-108, 2005
The definition of primary and secondary glioblastoma
H Ohgaki, P Kleihues
Clinical cancer research 19 (4), 764-772, 2013
IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas
T Watanabe, S Nobusawa, P Kleihues, H Ohgaki
The American journal of pathology 174 (4), 1149-1153, 2009
Overexpression of the EGF Receptor and p53 Mutations are Mutually Exclusive in the Evolution of Primary and Secondary Glioblastomas
K Watanabe, O Tachibana, K Sato, Y Yonekawa, P Kleihues, H Ohgaki
Brain pathology 6 (3), 217-223, 1996
Primary and secondary glioblastomas: from concept to clinical diagnosis
P Kleihues, H Ohgaki
Neuro-oncology 1 (1), 44-51, 1999
IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas
S Nobusawa, T Watanabe, P Kleihues, H Ohgaki
Clinical Cancer Research 15 (19), 6002-6007, 2009
I nternational S ociety of N europathology‐H aarlem C onsensus G uidelines for N ervous S ystem T umor C lassification and G rading
DN Louis, A Perry, P Burger, DW Ellison, G Reifenberger, A von Deimling, ...
Brain pathology 24 (5), 429-435, 2014
Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype
M Olivier, DE Goldgar, N Sodha, H Ohgaki, P Kleihues, P Hainaut, ...
Cancer research 63 (20), 6643-6650, 2003
Reversibility of ischemic brain damage
KA Hossmann, P Kleihues
Archives of Neurology 29 (6), 375-384, 1973
Genetic alterations and signaling pathways in the evolution of gliomas
H Ohgaki, P Kleihues
Cancer science 100 (12), 2235-2241, 2009
Topographic anatomy and CT correlations in the untreated glioblastoma multiforme
PC Burger, ER Heinz, T Shibata, P Kleihues
Journal of neurosurgery 68 (5), 698-704, 1988
Tumors associated with p53 germline mutations: a synopsis of 91 families.
P Kleihues, B Schäuble, A zur Hausen, J Estève, H Ohgaki
The American journal of pathology 150 (1), 1, 1997
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20